Researcher
Joris Vermeesch
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Laboratory for Cytogenetics and Genome Research (Division)
Responsible
From1 Jan 2008 → Today - Department of Human Genetics (Department)
Member
From27 Sep 2004 → Today
Infrastructure
1 - 3 of 3
- PACBIO; third -generation sequencing platform with Single Molecule Real Time technology (SMRT) (Consortium coordinator)
- EU-Genomics: EU Infrastructure for genomic analysis. (Consortium coordinator)
- Belgian Genome Biobank (Consortium coordinator)
Projects
1 - 10 of 63
- Impact of ccfDNA on clinical decision making in NEN patientsFrom8 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the functional role of the low copy repeats in the phenotypic variability of the 22q11.2 Deletion SyndromeFrom27 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Impact of ccfDNA on clinical decision making in NEN patientsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Sabbatical Joris Vermeesch: Computational analyses of large sequencing data setsFrom1 Oct 2022 → 30 Apr 2023Funding: BOF - mobility
- SymBioSys: Computationally mapping genomic heterogeneity from long read sequencing dataFrom1 Oct 2022 → TodayFunding: BOF - projects
- Implementation and validation of liquid biopsies as a diagnostic tool for early breast cancer detection in South African black womenFrom1 Sep 2022 → TodayFunding: VLIR-UOS South Initiatives
- Belgian Genome BiobankFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Remote allograft rejection diagnosis by epigenetic changes in circulating cell-free DNA in kidney transplanted patients.From1 Feb 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Mapping the role of the low copy repeats in the phenotypic variability of the 22q11 Deletion SyndromeFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 399
- Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies(2023)
Authors: Joris Vermeesch
Pages: 814 - 828 - Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophrenia(2023)
Authors: Ann Swillen, Joris Vermeesch
Pages: 2071 - 2080 - Noninvasive prenatal screening and maternal malignancy: role of imaging.(2023)
Authors: Liesbeth Lenaerts, Joris Vermeesch, Frédéric Amant
Pages: 1590 - 1598 - Preclinical workup using long-read amplicon sequencing provides families with de novo pathogenic variants access to universal preimplantation genetic testing(2023)
Authors: Olga Tsuiko, Tatjana Jatsenko, Sophie Debrock, Karen Peeraer, Arne Vanhie, Ellen Denayer, Eric Legius, Joris Vermeesch, Hilde Brems, Eftychia Dimitriadou
Pages: 511 - 519 - Expanded Non-invasive Prenatal Testing (NIPT) Can the Child's Right to an Open Future Help Set the Scope?(2023)
Authors: Neeltje Crombag, Joris Vermeesch, Pascal Borry
Pages: 41 - 49 - Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge(2022)
Authors: Lore Lannoo, Jeroen Breckpot, Nathalie Brison, Luc De Catte, Eftychia Dimitriadou, Eric Legius, Hilde Peeters, Olga Tsuiko, Joris Vermeesch, Griet Van Buggenhout, et al.
Pages: 1323 - 1330 - The 22q11.2 Low Copy Repeats(2022)
Authors: Joris Vermeesch
- Parental genomes segregate into distinct blastomeres during multipolar zygotic divisions leading to mixoploid and chimeric blastocysts(2022)
Authors: Tine De Coster, Olga Tsuiko, Eftychia Dimitriadou, Sophie Debrock, Karen Peeraer, Joris Vermeesch
- Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity(2022)
Authors: Stefania Tuveri, Koen Debackere, Lukas Marcelis, Nicolas Dierckxsens, Jonas Demeulemeester, Eftychia Dimitriadou, Daan Dierickx, Lucienne Michaux, Jan Cools, Thomas Tousseyn, et al.
Pages: 603 - 615 - Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets(2022)
Authors: Huiwen Che, Lore Lannoo, Nathalie Brison, Kris Van Den Bogaert, Koenraad Devriendt, Ellen De Langhe, Séverine Vermeire, Bram Verstockt, Kristel Van Calsteren, Joris Vermeesch
Patents
1 - 8 of 8
- Method for analysing cell-free nucleic acids (Inventor)
- Method for analysing cell-free nucleic acids (Inventor)
- High-throughput genotyping by sequencing low amounts of genetic material (Inventor)
- Method for analysing cell-free nucleic acids (Inventor)
- Haplotyping and copy number typing using polymorphic variant allelic frequencies (Inventor)
- Methods for haplotyping single cells (Inventor)
- HAPLOTYPING AND COPY NUMBER TYPING USING POLYMORPHIC VARIANT ALLELIC FREQUENCIES (Inventor)
- HIGH-THROUGHPUT GENOTYPING BY SEQUENCING LOW AMOUNTS OF GENETIC MATERIAL (Inventor)